Delivery Order SPE2DB20D1100-SPE2DB25FD6P6
- Not listed
- The Defense Logistics Agency awarded a $1,782.98 delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Promethegan 25 mg suppositories (12-count units). This is a firm fixed price, competitively awarded contract with no set-aside designation and a completion date of August 15, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child contract action, this delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,218.96 to AmerisourceBergen Drug Corp for the supply of Promethegan 12.5 mg suppositories (12-count packages). This firm fixed-price delivery order, issued on July 26, 2025, with completion targeted for July 28, 2025, represents a routine pharmaceutical procurement supporting federal medical supply requirements. The award was made through open competition with no set-aside designation, and performance will be executed at the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Promethegan 25 mg suppositories (12-count packages) valued at $1,383.72 with a completion date of August 1, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The order will be fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania location, where the company maintains its corporate headquarters as a major pharmaceutical distributor serving...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Promethegan 12.5 mg suppositories (12-count units) with a ceiling value of $1,950.24. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 18, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. No set-aside designation was applied to this procurement. This delivery order is executed under...
- The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a $1,794.40 firm fixed price delivery order to provide PROMETHEGAN 25 MG SUPPOSITORY 12S pharmaceutical products. This order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4568346280 ! PROMETHEGAN 25 MG SUPPOSITORY 12S, a pharmaceutical product. The contract has a firm fixed price of $1,679.42 and an ultimate completion date of May 27, 2025. It is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a significant $999,999,999.00...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,154.16, is for the delivery of PROMETHEGAN 25 MG SUPPOSITORY 12S medical supplies. It is a firm fixed-price delivery order contract with a completion date of March 31, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,256.80 firm-fixed-price delivery order is for the supply of PROMETHEGAN 12.5 MG SUPPOS 12S, a pharmaceutical product. The contract has an ultimate completion date of October 28, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,731,440 units of Promethazine 25 mg Suppository, with a ceiling value of $1,294.18. The contract is a Firm Fixed Price Delivery Order with a period of performance ending on March 31, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that...
- This federal contract award, valued at $2,356.50, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of PROMETHEGAN 25 MG SUPPOSITORY 12S, a pharmaceutical product, with a completion date of March 13, 2023. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FD6P6Delivery Order
The Defense Logistics Agency awarded a $7,329.92 delivery order to AmerisourceBergen Drug Corp for Promethegan 25 mg suppositories on July 25, 2025, with an ultimate completion date of July 28, 2025. This firm fixed price contract represents a non-set-aside competitive award to be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, fulfills this order as part of its broader role supplying pharmaceuticals and medical supplies to military and veteran healthcare systems. This delivery order operates under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. This comprehensive prime contract vehicle enables the company to supply a broad range of pharmaceutical products, generic and brand-name medications, vaccines, and specialized medical supplies globally to support military healthcare programs. The delivery order approach allows the Defense Logistics Agency to procure specific pharmaceutical items on an as-needed basis while leveraging the established indefinite contract framework and the vendor's established capability to meet federal medical supply requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.3k | 7/25/25 |